Q: Please comment on today's results. They seemed very good but the market does not agree as the stock has sold off sharply. Thanks
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: would appreciate your current thoughts on ARZ. Company online presentation reads well. Thanks
Q: After the recent earnings. Do you think the company has finally startered turning things around?
Q: Can you explain the recent run up in price?
Q: Can you plz comment on recent earnings and outlook of the company? Thanks.
Q: Thoughts on recent earnings? Is this a lost cause?
Q: Peter: ARZ has gone through a significant drop over the last few months. On the RBC website Morningstar has it as "undervalued". What is your view for the future of this stock?
Have a great day... Joe Zadel
Have a great day... Joe Zadel
Q: The CEO just made a large purchase of shares. Do you think this is a vote of confidence in the company?
Q: Can you please comment on recent earnings? Is it time to get out of the stock?
-
TIO Networks Corp (TNC $3.33)
-
Aralez Pharmaceuticals Inc. (ARZ $0.43)
-
Intrinsyc Technologies Corporation (ITC $1.75)
Q: I sold some of my TNC at a profit and bought some ARZ and some ITC. What do you think of these three companies and which ones will have the most potential going forward?
-
Aralez Pharmaceuticals Inc. (ARZ $0.43)
-
Premium Brands Holdings Corporation (PBH $90.51)
-
Exchange Income Corporation (EIF $65.57)
Q: I am thinking of selling ARZ and looking at PBH or EIF. Disregarding sectors, could I please have your opinion and what would favour or keep ARZ. Thanks
Q: Could you please comment on ARZ's drug right's acquisition this morning. Thanks
Q: Can you please comment on ARZ after today's fda approval for Yasprala?
Thanks
Sean
Thanks
Sean
Q: Could I have your view on ARZ going forward. They are awaiting to get their drug yosprala approved. Also could you tell me their cash poition and inside ownership. Thanks
Q: I bought this as Tribute awhile back as a small growing pharma. Since merger with Pozen it has only gone down. Is this valeant effect or too much debt?